摘要
Acute liver injury (ALI) is a serious syndrome that is associated with high mortality, but there are few effective treatments. The activation of NLRP3 inflammasome is associated with ALI. Oridonin is a natural substance with an anti-inflammatory effect and has been reported to be an inhibitor of NLRP3. The aim of this study was to investigate the protective effect of oridonin on d-galactosamine (d-GalN)/lipopolysaccharide (LPS)-induced ALI and whether the effect is mediated by NLRP3. Mice were pretreated with oridonin (5 or 10 mg/kg) for 3 days. Then, they were injected with d-GalN (400 mg/kg) and LPS (40 mu g/kg). The levels of inflammatory factors were measured by RT-PCR, Western blot, and enzyme-linked immunosorbent assay. We confirmed that oridonin significantly alleviated ALI induced by d-GalN/LPS in mice. Oridonin markedly decreased the inflammatory response by reducing the levels of inflammatory cytokines. More importantly, oridonin markedly reduced the expression of NLRP3, caspase-1, IL-18, and IL-1 beta. This study showed that oridonin has a protective effect on d-GalN/LPS-induced ALI, and the underlying mechanisms may be associated with the inhibition of the NLRP3 inflammatory pathways.
学科与关键词
- Effect of oridonin on oxylipins in the livers of mice with acute liver injury induced by D-galactosamine and lipopolysaccharideZhan, Zhikun; Zhang, Tao; Dai, Fahong; Wen, Xin; Chen, Yulian; Jiang, Huanguo; Gu, Tanwei; Cheng, Yuan*; Tang, Lan*International Immunopharmacology, 2022, 102: 108387.被引 5
- Oridonin Alters Hepatic Urea Cycle via Gut Microbiota and Protects against Acetaminophen-Induced Liver InjuryHong, Mu-keng; Liu, Hai-hua; Chen, Gui-hong; Zhu, Jun-qing; Zheng, Song-yuan; Zhao, Di; Diao, Jianxing; Jia, Hui; Zhang, Ding-ding; Chen, Shi-xian*; Gao, Lei*; Li, Juan*Oxidative Medicine and Cellular Longevity, 2021, 2021.被引 10
- Oridonin restores hepatic lipid homeostasis in an LXRa-ATGL/EPT1 axis-dependent mannerChen, Yulian; Jiang, Huanguo; Zhan, Zhikun; Lu, Jindi; Gu, Tanwei; Yu, Ping; Liang, Weimin; Zhang, Xi; Zhong, Shilong; Tang, Lan*Journal of Pharmaceutical Analysis, 2023, 13(11): 1281-1295.
